Article Versions Notes

Kim S, Lee S, Lee H, Ju S, Park S, Kwon D, Yoo J-W, Yoon I-S, Min DS, Jung Y-S, et al. A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats. Pharmaceutics. 2020; 12(9):843. https://doi.org/10.3390/pharmaceutics12090843

Kim, Soojin, Seunghyun Lee, Hanju Lee, Sanghyun Ju, Sohee Park, Doyoung Kwon, Jin-Wook Yoo, In-Soo Yoon, Do Sik Min, Young-Suk Jung, and et al. 2020. "A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats" Pharmaceutics 12, no. 9: 843. https://doi.org/10.3390/pharmaceutics12090843

Kim, S., Lee, S., Lee, H., Ju, S., Park, S., Kwon, D., Yoo, J.-W., Yoon, I.-S., Min, D. S., Jung, Y.-S., & Jung, Y. (2020). A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats. Pharmaceutics, 12(9), 843. https://doi.org/10.3390/pharmaceutics12090843